Exelixis (EXEL) Amortizatization of Intangibles (2010 - 2019)
Exelixis (EXEL) recorded quarterly Amortizatization of Intangibles of $704000.0 in Q3 2019, up 6.83% quarter-over-quarter from $659000.0 in Q2 2019, and down 74.23% on a YoY basis from $2.7 million in Q3 2018.
Exelixis (EXEL) Amortizatization of Intangibles (2010 - 2019) Analysis & Trends
Exelixis' Amortizatization of Intangibles history runs 9 years deep, the most recent figure standing at $704000.0 for Q3 2019.
- In Q3 2019, Amortizatization of Intangibles fell 74.23% year-over-year to $704000.0; the TTM figure through Sep 2019 stood at -$6.2 million (down 177.9% YoY), while the FY2018 annual figure was $2.9 million, changed N/A from the prior year.
- Amortizatization of Intangibles was $704000.0 for Q3 2019 at Exelixis, up from $659000.0 in the prior quarter.
- In the past five years, Amortizatization of Intangibles ranged from a high of $7.7 million in Q1 2015 to a low of -$7.7 million in Q1 2019.
- Historically, Amortizatization of Intangibles has averaged $2.7 million across 4 years, with a median of $3.8 million in 2015.
- The sharpest annual moves came in 2015 and 2019: Amortizatization of Intangibles climbed 9.83% in 2015, then tumbled 74.23% in 2019.
- A 4-year view of Amortizatization of Intangibles shows it stood at $4.8 million in 2015, then advanced by 9.19% to $5.3 million in 2016, then tumbled by 97.69% to $122000.0 in 2018, then surged by 477.05% to $704000.0 in 2019.
- The last three Amortizatization of Intangibles figures came in at $704000.0 (Q3 2019), $659000.0 (Q2 2019), and -$7.7 million (Q1 2019), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | 13,267.00 |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | - |
| 10 | Exelixis | 13.61 Bn | 12.83 Bn | 590.86 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 27, 2019 | 704,000.00 |
| Sep 27, 2019 | 704,000.00 |
| Jun 28, 2019 | 659,000.00 |
| Jun 28, 2019 | 659,000.00 |
| Mar 29, 2019 | -7.73 Mn |
| Mar 29, 2019 | -7.73 Mn |
| Dec 28, 2018 | 122,000.00 |
| Dec 28, 2018 | 122,000.00 |
| Sep 28, 2018 | 2.73 Mn |
| Sep 28, 2018 | 2.73 Mn |
| Mar 31, 2016 | 5.29 Mn |
| Mar 31, 2016 | 5.29 Mn |
| Dec 31, 2015 | 4.84 Mn |
| Dec 31, 2015 | 4.84 Mn |
| Sep 30, 2015 | 5.30 Mn |
| Sep 30, 2015 | 5.30 Mn |
| Jun 30, 2015 | 7.22 Mn |
| Jun 30, 2015 | 7.22 Mn |
| Mar 31, 2015 | 7.68 Mn |
| Mar 31, 2015 | 7.68 Mn |